Anadolu Medical Center
| Turkey | Thailand | South Korea | |
| Mohs microsurgery | from AUD $3,191 | from AUD $3,191 | from AUD $3,191 |
| Melanoma surgery | from AUD $5,077 | from AUD $5,802 | from AUD $10,880 |
| Immunotherapy with Keytruda (Pembolizumab) | from AUD $4,787 | from AUD $11,605 | from AUD $7,543 |
| Wide excision of melanoma | from AUD $5,802 | - | - |
| Topical therapy of melanoma | from AUD $2,103 | - | - |
Professor Bulent Karagoz has performed over 900 melanoma-related procedures at Anadolu Medical Center, specialising in ways to trigger the immune system to fight skin cancer.
Professor Eda Tanrikulu focuses on metastatic malignant melanoma and ranked third in Turkey's prestigious national medical specialty exam.
Dr. Mustafa Solak is a clinical oncologist at Hisar Hospital Intercontinental in Istanbul. He completed a fellowship at the prestigious Hacettepe University Cancer Institute. Dr. Solak previously practiced at The University of Texas MD Anderson Cancer Center. He treats a variety of complex cancers, including lung, breast, and gastrointestinal malignancies.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Turkish JCI-accredited centres offer melanoma treatments including wide surgical excision, Mohs microsurgery, and immunotherapy with pembrolizumab. Specialist clinics use technologies like the Halcyon radiation system for targeted therapy. Leading hospitals also provide rare options such as Natural Killer cell therapy and Actinium-225 radionuclide therapy.
Bookimed Expert Insight: Anadolu Medical Center holds OECI and ESMO accreditations. It maintains an official affiliation with Johns Hopkins Medicine. Prof. Dr. Yesim Yildirim there specialises in melanoma immunotherapy. This combination of US clinical standards and skin cancer expertise allows for personalised treatment protocols.
Patient Consensus: Patients note that second opinions and pathology revisions in Turkey provide clarity for treatment. The speed of diagnostics is highlighted. Turkish specialists typically complete full melanoma examinations within 3 days.
Turkish oncology centres provide melanoma care meeting international benchmarks. Major facilities hold JCI accreditation. They often follow American protocols through affiliations with institutions like Johns Hopkins Medicine. Specialists offer modern therapies. These include Keytruda immunotherapy, Mohs microsurgery, and Halcyon radiotherapy platforms.
Bookimed Expert Insight: Anadolu Medical Center maintains a formal affiliation with Johns Hopkins Hospital. This link helps treatment protocols strictly match top-tier American standards. Their nuclear medicine unit treats thousands of patients annually. Packages often include Actinium-225 therapy for complex cases. These are priced between A$31,700 and A$34,100. This provides access to specialised radiopharmaceuticals not always available in smaller regional centres.
Patient Consensus: Patients in Turkey report thorough diagnostic processes. They often complete full melanoma staging within 3 days. They value the dedicated translators and the ease of getting second opinions. These opinions align with Israeli or European data.
Australian melanoma patients travelling to Turkey usually complete surgery or initial immunotherapy within 1 to 4 weeks. Recovery takes 1 to 6 weeks depending on procedure complexity. JCI-accredited centres like Anadolu Medical Center provide rapid consultations. They often start treatment within days of arrival.
Bookimed Expert Insight: Turkish oncology centres like Memorial Göstepe Hospital use multidisciplinary tumour boards to review every case. Surgeons, oncologists, and radiologists all weigh in on one plan within 48 hours. For Australians, this eliminates the lengthy specialist wait times common at home.
Patient Consensus: Patients note that Turkish clinics complete diagnostic checks within 3 days. They value the helpfulness of Turkish translators. They suggest confirming all logistics and transfer times with coordinators before arrival.
Language barriers are rare at major Turkish oncology centres. This is because they provide professional interpreters and English-speaking specialists as standard. Facilities like Anadolu Medical Center maintain Johns Hopkins affiliations. These clinics employ dedicated international departments to 도와 help with clear communication. This covers everything from diagnosis through to surgery and immunotherapy.
Bookimed Expert Insight: While most specialists speak English, large centres like Medipol Mega serve over 1,000,000 patients annually. In high-volume environments, personal translators become vital. Australian patients should choose clinics like Anadolu Medical Center. They specifically bundle medical follow-up by specialists. This helps clear instructions before flying home.
Patient Consensus: Patients note that translators like Madina at LIV Hospital help clarify complex medical details during consultations. Experience in Turkey shows that while clinics are busy, friendly staff and professional interpreters answer all medical questions.